How Your Study’s Informed Consent Can Help Simplify Study Startup
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
REVIEWS Become a Member Join Advarra’s review teams to contribute your expertise to advancing research. Our committees play a vital
Advarra meets the growing needs of oncology by offering robust human subject protections that cancer research institutions expect.
In the complex landscape of clinical trials, the data monitoring committee (DMC) serves as the cornerstone at the intersection of
Join the Gene Therapy Network to accelerate study activation, gain IBC support, and position your site as a preferred choice for sponsors.
Advarra’s biosafety experts streamline startup for gene therapy trials with comprehensive IBC reviews and proven rapid turnaround times.
In an era where clinical trials are increasingly global, it’s more imperative than ever to leverage international expertise. Data and
Comprehensive IBC submissions require detailed materials, including investigator CVs, safety protocols, and site-specific SOPs for study agent handling.
The revised Common Rule introduces new exemptions, refined consent elements, and alters IRB oversight for multisite and minimal-risk research.
Navigate federal grant applications with Advarra’s expert checklist. Our streamlined process ensures compliance and participant protections for your research.
Advarra’s institutional review board (IRB) strives to protect participant rights and welfare throughout the research process.
EAC Services Endpoint Adjudication Committee (EAC) Tailored EAC services designed to meet the unique needs of your study Clinical studies